Psychedelic research shows no sign of slowing down as researchers carried over the New Year’s momentum into February. Over the last month, we saw that psilocybin-assisted therapy’s effects on depression could last for up to 12 months. MDMA-assisted therapy led to reductions in alcohol use in patients with PTSD. At the same time, the first study assessing the effects of MDMA on fear extinction…


Previous articlePT298 – Michael Sapiro, PsyD – Vital Psychedelic Conversations
Next articlePT299 – Ed Prideaux – HPPD (Hallucinogen Persisting Perception Disorder): A Synopsis